Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

LPA signaling is regulated through the primary cilium: a novel target in glioblastoma.

Loskutov YV, Griffin CL, Marinak KM, Bobko A, Margaryan NV, Geldenhuys WJ, Sarkaria JN, Pugacheva EN.

Oncogene. 2018 Mar;37(11):1457-1471. doi: 10.1038/s41388-017-0049-3. Epub 2018 Jan 11.

PMID:
29321663
2.

Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.

Herting CJ, Chen Z, Pitter KL, Szulzewsky F, Kaffes I, Kaluzova M, Park JC, Cimino PJ, Brennan C, Wang B, Hambardzumyan D.

Glia. 2017 Dec;65(12):1914-1926. doi: 10.1002/glia.23203. Epub 2017 Aug 24.

PMID:
28836293
3.

Corticosteroids compromise survival in glioblastoma.

Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Holland EC, Hambardzumyan D.

Brain. 2016 May;139(Pt 5):1458-71. doi: 10.1093/brain/aww046. Epub 2016 Mar 28.

4.

Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model.

Lemasson B, Wang H, Galbán S, Li Y, Zhu Y, Heist KA, Tsein C, Chenevert TL, Rehemtulla A, Galbán CJ, Holland EC, Ross BD.

Neoplasia. 2016 Feb;18(2):82-9. doi: 10.1016/j.neo.2015.11.014.

5.

In vivo Mn-enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model.

Suero-Abreu GA, Praveen Raju G, Aristizábal O, Volkova E, Wojcinski A, Houston EJ, Pham D, Szulc KU, Colon D, Joyner AL, Turnbull DH.

Neoplasia. 2014 Dec;16(12):993-1006. doi: 10.1016/j.neo.2014.10.001.

6.

Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature.

Kim B, Yang J, Hwang M, Choi J, Kim HO, Jang E, Lee JH, Ryu SH, Suh JS, Huh YM, Haam S.

Nanoscale Res Lett. 2013 Sep 26;8(1):399. doi: 10.1186/1556-276X-8-399.

7.

Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma.

Huang R, Vider J, Kovar JL, Olive DM, Mellinghoff IK, Mayer-Kuckuk P, Kircher MF, Blasberg RG.

Clin Cancer Res. 2012 Oct 15;18(20):5731-40. doi: 10.1158/1078-0432.CCR-12-0374. Epub 2012 Aug 22.

8.

DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma.

Galbán S, Lemasson B, Williams TM, Li F, Heist KA, Johnson TD, Leopold JS, Chenevert TL, Lawrence TS, Rehemtulla A, Mikkelsen T, Holland EC, Galbán CJ, Ross BD.

PLoS One. 2012;7(4):e35857. doi: 10.1371/journal.pone.0035857. Epub 2012 Apr 20.

9.

Characterization of a human tumorsphere glioma orthotopic model using magnetic resonance imaging.

Wong K, Young GS, Makale M, Hu X, Yildirim N, Cui K, Wong ST, Kesari S.

J Neurooncol. 2011 Sep;104(2):473-81. doi: 10.1007/s11060-010-0517-x. Epub 2011 Jan 15.

10.

Multiple-mouse MRI with multiple arrays of receive coils.

Ramirez MS, Esparza-Coss E, Bankson JA.

Magn Reson Med. 2010 Mar;63(3):803-10. doi: 10.1002/mrm.22236.

11.

Modeling Adult Gliomas Using RCAS/t-va Technology.

Hambardzumyan D, Amankulor NM, Helmy KY, Becher OJ, Holland EC.

Transl Oncol. 2009 May;2(2):89-95.

12.

mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M, Holland EC.

Neoplasia. 2005 Apr;7(4):356-68.

13.

Imaging in neurooncology.

Jacobs AH, Kracht LW, Gossmann A, Rüger MA, Thomas AV, Thiel A, Herholz K.

NeuroRx. 2005 Apr;2(2):333-47. Review.

14.

High-resolution longitudinal screening with magnetic resonance imaging in a murine brain cancer model.

Bock NA, Zadeh G, Davidson LM, Qian B, Sled JG, Guha A, Henkelman RM.

Neoplasia. 2003 Nov-Dec;5(6):546-54.

Supplemental Content

Support Center